PREPARATION AND EVALUATION OF DROTAVERINE HCL ORAL DISINTEGRATING TABLETS USING SOLID MIXTURE TECHNIQUE
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i6.24867Keywords:
Drotaverine HCl, Hydroxypropyl methylcellulose, Nil, Solid mixture, Taste masking, oral disintegrating tabletAbstract
Objective: The objective of this study is to formulate orally disintegrating taste masked tablets of drotaverine HCl using solid mixture technique.
Methods: Taste masked drug-polymer solid mixtures of drotaverine HCl were prepared by using hydroxypropyl methylcellulose (HPMC) 3 cps and rxcipient® FM1000/calcium silicate (rxcipient) as carriers employing kneading method using varying drug-polymer ratios of 1:1, 1:5, 1:7.5, and 1:9. Prepared drug-polymer mixtures evaluated for taste masking, and the ratio of drug-polymer is optimized. The granules and tablets prepared with optimized drug-polymer ratio were evaluated for pre- and post-compression parameters, in vitro dissolution studies, Fourier-transformation infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and X-ray diffractometry (XRD) studies.
Results: The drug:polymer ratios 1:7.5 with rxcipient and 1:9 with HPMC were optimized based on taste evaluation. The pre-compression results showed that all the formulae have good flow properties. The post-compression evaluations showed that all the formulae met the specifications of orally disintegrating tablets. From all the prepared taste masked drotaverine HCl tablets, R10 formulation consisting of 4% croscarmellose sodium and H9 formulation consisting of 3% croscarmellose sodium, 3% sodium starch glycolate, and 2% microcrystalline cellulose shown more than 99% drug release in 60 min, and both the formulations showed better taste masking and were meting oral disintegrating tablet (ODT) parameters. The optimized formulation was characterized by FTIR, DSC, and XRD studies and found no incompatibility.
Conclusion: The results demonstrated that the prepared drotaverine HCl ODT showed better taste masking and meeting the parameters of ODT formulations R10 and H9. The present solid mixture technique can be effectively used for taste masking.
Downloads
References
Sabitri B, Snehamayee M. Recent approaches of solid dispersion: A new concept toward oral bioavailability. Asain J Pharm Clin Res 2018;11:72-8.
Anusha P, Nirajana A, Mohammed S, Jilani S, Murali C, Harish G.Development and evaluation of drotaverine taste masked tablets with improved dissolution efficiency using sold dispersion technique. India J Res PB 2013;1:275-80.
Ujwala B, Dinesh S, Sarika Z, Varsha K, Nanda R. Development and evaluation of drotaverine taste masked tablets with improved dissolution efficiency using sold dispersion technique. Res J Pharm Tech 2014;7: 301-6.
Srikanth M, Uhumwangho M, Sunil S, Sreenivasa N, Ravi C, Murthy KR. Design and evaluation of taste masked drotaverine HCl orodispersible tablets using polymethacrylate polymers. Pharm Lett 2010;2:223-31.
Pandey B, Mallik S, Ahmad S. Coprocessing of superdisintegrants for drug release of taste masked drotaverine HCl. Novel Sci IJPS 2012;1:758-63.
Fulla M, Israa H, Samira F. Taste masking of prifinum bromide in orodispersible tablets. Int J Pharm Pharm Sci 2014;6:315-9.
Shivangi S, Navneet V. Taste masked orodispersible tablets. A highly patient compliant dosage form. Asian J Pharm Clin Res 2016;9:385-91.
Aziz M, Salahuddin M, Ghulam M, Abdul R. Formulation and in-vitro evaluation of deferasirox oro-dispersible tablets. Int J Pharm Pharm Sci 2014;6:203-9.
Raghavendra N, Mahesh K, Srikanth M, Kistayya C, Mahipal B. Development and evaluation of fast dissolving tablets of fosinopril by sublimation method. Int J Pharm Sci Drug Res 2012;4:230-5.
Kumar R, Swati P, Patil M, Sachin R, Mahesh S. Formulation evaluation of mouth dissolving tablets of fenofibrate using sublimation technique. Int J Chem Tech Res 2009;1:840-50.
Uddhav B, Kishore G, Nancy P, Sanjeevani A, Shalaka D. Formulation and evaluation of sublimed fast melt tablets of levocetirizine dihydrochloride. Int J Pharm Sci Res 2010;2:76-80.
Madgulkar A, Kadam S, Pokharkar V. Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology. AAPS PharmSciTech 2008;9:998- 1005.
USP30-NF25. The Official Compendia of Standards. The United States Pharmacopoeial Convention. Powder Flow. (e book); 2007. p. 643.
TRAIN D. Some aspects of the property of angle of repose of powders. J Pharm Pharmacol 1958;10:127-35T.
USP30-NF25. The Official Compendia of Standards. The United States Pharmacopoeial Convention. Bulk Density and Tapped Density (e book); 2007. p. 242.
Craick DJ. The flow properties of starch powders and mixtures. J Pharm Pharmacol 1958;10:10.
Indian Pharmacopoeia. Government of India, Ministry of Health and Family Welfare, the Indian Pharmacopeia Commission. Ghaziabad, India: Indian Pharmacopoeia; 2010. p. I, 187-93.
Bi YX, Sunada H, Yonezawe Y, Danzo K. Evaluation of rapidly disintegrating tablets. Drug Dev Ind Pharm 1999;25:571-81.
Sivaprasad S, Ahad HA, Sreenivasulu R, Reddy BK, Mahesh CH, Kranthi G, et al. Novel approach in designing of mouth dissolving tablets for bitter drugs taking clozapine as model drug. Pharm Lett 2011;3:113-20.
Subrahmanian S, Sankar V, Asha A. Formulation and evaluation of cetrizine dihydrochloride orodispersible tablet. Pak J Pharm Sci 2010;23:232-5.
Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 2005;292:29-41.
Uchida T, Nakamura T, Tanigake A. The effect of various substances on the suppression of the bitterness of quinine-human gustatory sensation, binding and taste sensor studies. Chem Pharm Bull (Tokyo) 2002;50:1589-93.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
